Professional Documents
Culture Documents
“Approved”
by the Methodological Council of
The Department of Internal Medicine №3
Head of the department
______________________Professor O.B. Iaremenko
GUIDELINE OF LESSON
(TRAINING MANUAL)
Kyiv 2019
1
1. The topic actuality and the goal of the lesson. Shock is a life-
threatening circulatory disorder that leads to tissue hypoxia and a
disturbance in microcirculation. There are many different causes of
shock, which are classified into cardiogenic shock (e.g., as a result of
acute heart failure or cardiac tamponade), hypovolemic shock (e.g.,
following massive blood or fluid loss), and shock due to a disturbance in
the fluid distribution in the body (septic, anaphylactic, and neurogenic
shock). The common clinical findings are hypotension and tachycardia,
accompanied by specific symptoms related to the cause of shock.
Hypoxia can result in organ damage and complex metabolic disorders
such as kidney failure, DIC (disseminated intravascular coagulation),
ARDS (acute respiratory distress syndrome), and circulatory collapse.
Management of shock involves circulatory support and the treatment of
the underlying cause. Shock is associated with a very high mortality rate.
2. Learning competencies (attributions)
1. To have an idea about different types of shock: hypovolemic, cardiogenic,
obstructive, distributive, including anaphylactic and septic shocks.
2. To know mechanisms leading to different types of shock: hypovolemic,
cardiogenic, obstructive, distributive, including anaphylactic and septic
shocks
3. To be able to diagnosis different types of shock.
4. To be able to management of patients presenting with shock.
3. The structure of the lesson
Stages of shock
2. Progressive phase
Worsening hypotension
Hypoperfusion of peripheral tissues → generalized
tissue hypoxia → anaerobic metabolism in the underperfused organs
→ lactic acidosis → worsening tachypnea
Precapillary dilation and postcapillary constriction of the blood vessels
→ pooling and stasis of blood in the capillary bed → decreased cardiac
output and formation of microthrombi in the capillaries → DIC and
further hypoxic injury to tissues
3
Acidosis, cerebral hypoperfusion → altered mental status
Dilated Cardiomyopathy
l Ischemic
l Viral/bacterial
l Toxin-induced
l Rheumatologic
l Thyroid disease
l Pheochromocytoma
l Congenital
l Peripartum
l Sarcoidosis
Hypertrophic cardiomyopathy
4
Restrictive cardiomyopathy
Myocarditis
Takotsubo Cardiomyopathy
Atrial Myxoma
Orthotopic Transplant Rejection
Cardiac Trauma
lAtrial Myxoma
Orthotopic Transplant Rejection
Class I II III IV
Blood loss < 15% 15–30% 30–40% > 40%
Heart rate < 100 100–120 120–140 > 140
Systolic blood Normal Normal ↓ ↓
pressure
Pulse pressure Normal or ↓ ↓ ↓
↑
Respiratory rate 14–20 20–30 30–40 > 35
Urine output > 30 mL/hr 20–30 mL/hr 5–15 mL/hr Absent
Mental status Anxious Mildly Anxious, Confused,
anxious confused lethargic
5
Figure 1. Clinical pathway for diagnosing and managing shock
• Evaluate volume status and preload (Class II) Continue resuscitation and
• Physical examination (Indeterminate) initiate appropriate targeted
• Ultrasound (Class II) therapies
• Passive leg raise (Class II) (Class II)
• Noninvasive cardiac output monitors (Class III)
No
Type and etiology clear?
• Further
Yes diagnostics
• Laboratory tests including CBC,
chemistries, liver function tests, troponin,
ABG/VBG, lactate (Class II), central venous
oxygen (Class II)
• Imaging with chest x-ray, CT scan No
No Type and etiology clear?
Yes
Continue resuscitation, reassess clinically
6
Table 4. Quick sequential organ failure assessment (qSOFA) score in patient
potentially at risk of dying from sepsis
Criteria Points
Respiratory rate ≥22/min 1
Change in mental status 1
Systolic blood pressure ≤100 mmHg 1
A qSOFA score of ≥2 points indicates organ dysfunction.
Peripheral vascular ↑ ↑ ↓ ↓ ↓
resistance
Mixed venous oxygen ↓ ↓ ↑ ↓ ↓
saturation (SvO2)
7
Table 7. Clinical criteria for diagnosing anaphylaxis
Anaphylaxis is highly likely when any one of the following 3 criteria are fulfilled:
1. Acute onset of an illness (minutes to several hours) with involvement of the skin,
mucosal tissue, or both
(eg, generalized hives, pruritus or flushing, swollen lips-tongue-uvula)
AND AT LEAST ONE OF THE FOLLOWING
a. Respiratory compromise (eg, dyspnea, wheeze-bronchospasm, stridor, reduced PEF,
hypoxemia)
b. Reduced BP or associated symptoms of end-organ dysfunction (eg, hypotonia [collapse],
syncope,
incontinence)
2. Two or more of the following that occur rapidly after exposure to a likely allergen for
that patient (minutes to
several hours):
a. Involvement of the skin-mucosal tissue (eg, generalized hives, itch-flush, swollen lips-
tongue-uvula)
b. Respiratory compromise (eg, dyspnea, wheeze-bronchospasm, stridor, reduced PEF,
hypoxemia)
c. Reduced BP or associated symptoms (eg, hypotonia [collapse], syncope, incontinence)
d. Persistent gastrointestinal symptoms (eg, crampy abdominal pain, vomiting)
3. Reduced BP after exposure to known allergen for that patient (minutes to several hours):
a. Infants and children: low systolic BP (age specific) or greater than 30% decrease in
systolic BP*
b. Adults: systolic BP of less than 90 mm Hg or greater than 30% decrease from that
person’s baseline
8
Figure 2. Protocol for initial management of anaphylaxis
F
i Cardio-respiratory arrest Upper airway, lower respiratory or Consider lower
r cardiovascular symptoms or signs threshold for adrenaline
s and anaphylaxis is likely if:
t Give I.M. ADRENALINE - previous severe
- reaction
l Treat as per protocol
i if possible, remove - exposure to
n allergen known/likely
e Call for help allergen
- co-existent asthma
I.M. adrenaline dose
0.01 ml/kg adrenaline
(1mg/ml) or Hypotension or Stridor Wheeze
- hight flow - hight flow
7.5 to 25 kg: 0.15 collapse
- hight flow oxygen oxygen oxygen
mg adrenaline - sit up - sit up
- lie down, extremities
auto-injector elevated - nebulized - nebulized β-
≥25 kg: 0.3 mg - normal saline 20 adrenaline 2 agonist
adrenaline auto - ml/kg i.v. or
injector intraosseous
- call for ICU support
6. Recommended literature:
6.1. Basic (textbook or international Guideline):
1. Singer M., Deutschman C., Seymour C., et al. The Third
International Consensus Definitions for Sepsis and Septic Shock
(Sepsis-3). JAMA 2016;315:801–10.
2. Muraro A., Roberts G., Worm M. Anaphylaxis: guidelines from
the European Academy of Allergy and Clinical Immunology.
Allergy. 2014 Aug;69(8):1026-45. doi: 10.1111/all.12437. Epub
2014 Jun 9.
10
6.2. Additional (articles or national Guidelines):
1. Dellinger R., Levy M., Rhodes A., et al. Surviving sepsis
campaign: international guidelines for management of severe
sepsis and septic shock: 2012. Crit Care Med 2013;41:580–637.
11